awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47323988-9B50CE1E-3364-45C6-BC02-9D3327DD15AD
Q47323988-9B50CE1E-3364-45C6-BC02-9D3327DD15AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47323988-9B50CE1E-3364-45C6-BC02-9D3327DD15AD
Front-line therapy of advanced ovarian cancer: new approaches.
P2860
Q47323988-9B50CE1E-3364-45C6-BC02-9D3327DD15AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47323988-9B50CE1E-3364-45C6-BC02-9D3327DD15AD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
758b0e68358a89f52fffcb56d4c6bf70a200097c
P2860
Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-